Advertisement

Heart and Vessels

, Volume 33, Issue 9, pp 1060–1067 | Cite as

Persistence of an iatrogenic atrial septal defect after a second-generation cryoballoon ablation of atrial fibrillation

  • Tomonori Watanabe
  • Shinsuke Miyazaki
  • Takatsugu Kajiyama
  • Sadamitsu Ichijo
  • Takamitsu Takagi
  • Miyako Igarashi
  • Hiroaki Nakamura
  • Hiroshi Taniguchi
  • Hitoshi Hachiya
  • Yoshito Iesaka
Original Article

Abstract

Persistent iatrogenic atrial septal defects (iASDs) can be observed after intervention requiring a left atria (LA) access, including pulmonary vein isolation (PVI) of atrial fibrillation (AF). We investigated the incidence of iASDs post-second-generation cryoballoon ablation and the pre-procedural predictors. Eighty-three paroxysmal AF patients underwent PVI using second-generation cryoballoons. The LA was accessed with single 15-Fr steerable sheaths following a radiofrequency transseptal puncture, and the iASD was evaluated with transthoracic echocardiography (TTE), a median of 9.3 (7.1–13.3) months post-procedure. All patients underwent pre-procedural contrast-enhanced multi-detector computed tomography (CT) to evaluate the LA and PV anatomy. iASDs were detected by TTE in 7 (8.4%) patients, a median of 15.5 (6.8–17.3) months post-procedure. Patients with iASDs had significantly larger LA volumes and smaller atrial septal angles, defined as the angle between the atrial septum and sagittal line on the horizontal section at the height of the fossa ovalis, which could be the transseptal puncture site measured on CT, and more likely hypertension than those without. Multivariate analyses revealed that the atrial septal angle was the sole predictor of iASDs [odds ratio 0.764, 95% confidence interval (CI) 0.624–0.935, p = 0.009], and the optimal cut-off value was 57.5° (sensitivity 85.7%, specificity 88.2%, 95% CI 0.873–0.995, p < 0.0001). Patients with iASDs were asymptomatic and had no adverse clinical events during a 17.7 (14.4–25.8) month median follow-up. iASDs were still detectable in 8.4% of patients a median of 15.5 months after the second-generation CB ablation, and the atrial septal angle might aid in predicting persistent iASDs.

Keywords

Iatrogenic atrial septal defect Cryoballoon ablation Atrial fibrillation Pulmonary vein isolation Transseptal puncture 

Notes

Acknowledgements

We would like to thank Mr. John Martin for his help in the preparation of the manuscript.

Compliance with ethical standards

Conflict of interest

The author(s) declare that they have no competing interests.

Financial support

None.

Disclosures

None.

Supplementary material

380_2018_1147_MOESM1_ESM.jpg (96 kb)
Fig. 1. Panel A is a short axis image on TTE. Panel B is an image of the horizontal plane of the enhanced CT. The location of the iASD is evaluated by the ratio that was calculated with the distance from the basal atrial septum to the iASD (a) divided by the distance from the basal atrial septum to the aortic cusp (b). (JPEG 95 kb)
380_2018_1147_MOESM2_ESM.jpg (107 kb)
Fig. 2. The atrial septal angle and direction of the transseptal puncture in patients without an iASD (panel A: The angle is 70 degree) and with an iASD (panel B: The angle is 55 degree) are shown. Please see the explanation in the Discussion section. (JPEG 107 kb)
380_2018_1147_MOESM3_ESM.jpg (164 kb)
Fig. 3. The different angles of transseptal lines (blue arrows) against the atrial septum are shown. Please see the explanation in the Discussion section. (JPEG 163 kb)

References

  1. 1.
    Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666CrossRefPubMedGoogle Scholar
  2. 2.
    Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D, Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9:632–696CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN, Cryoablation Investigators STOPAF (2013) Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol 61:1713–1723CrossRefPubMedGoogle Scholar
  4. 4.
    Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, FIRE AND ICE Investigators (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374:2235–2245CrossRefPubMedGoogle Scholar
  5. 5.
    Hammerstingl C, Lickfett L, Jeong KM, Troatz C, Wedekind JA, Tiemann K, Lüderitz B, Lewalter T (2006) Persistence of iatrogenic atrial septal defect after pulmonary vein isolation—an underestimated risk? Am Heart J 152:362CrossRefPubMedGoogle Scholar
  6. 6.
    Rillig A, Meyerfeldt U, Birkemeyer R, Treusch F, Kunze M, Jung W (2008) Persistent iatrogenic atrial septal defect after pulmonary vein isolation: incidence and clinical implications. J Interv Card Electrophysiol 22:177–181CrossRefPubMedGoogle Scholar
  7. 7.
    McGinty PM, Smith TW, Rogers JH (2011) Transseptal left heart catheterization and the incidence of persistent iatrogenic atrial septal defects. J Interv Cardiol 24:254–263CrossRefPubMedGoogle Scholar
  8. 8.
    Singh SM, Douglas PS, Reddy VY (2011) The incidence and long-term clinical outcome of iatrogenic atrial septal defects secondary to transseptal catheterization with a 12F transseptal sheath. Circ Arrhythm Electrophysiol 4:166–171CrossRefPubMedGoogle Scholar
  9. 9.
    Chan NY, Choy CC, Lau CL, Lo YK, Chu PS, Yuen HC, Mok NS, Tsui PT, Lau ST (2011) Persistent iatrogenic atrial septal defect after pulmonary vein isolation by cryoballoon: an under-recognized complication. Europace 13:1406–1410CrossRefPubMedGoogle Scholar
  10. 10.
    Cronin EM, Collier P, Wazni OM, Griffin BP, Jaber WA, Saliba WI (2013) Persistence of atrial septal defect after cryoballoon ablation of atrial fibrillation. J Am Coll Cardiol 62:1491–1492CrossRefPubMedGoogle Scholar
  11. 11.
    Sieira J, Chierchia GB, Di Giovanni G, Conte G, De Asmundis C, Sarkozy A, Droogmans S, Baltogiannis G, Saitoh Y, Ciconte G, Levinstein M, Brugada P (2014) One year incidence of iatrogenic atrial septal defect after cryoballoon ablation for atrial fibrillation. J Cardiovasc Electrophysiol 25:11–15CrossRefPubMedGoogle Scholar
  12. 12.
    Coulombe N, Paulin J, Su W (2013) Improved in vivo performance of second-generation cryoballoon for pulmonary vein isolation. J Cardiovasc Electrophysiol 24:919–925CrossRefPubMedGoogle Scholar
  13. 13.
    Martins RP, Hamon D, Césari O, Behaghel A, Behar N, Sellal JM, Daubert JC, Mabo P, Pavin D (2014) Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation. Heart Rhythm 11:386–393CrossRefPubMedGoogle Scholar
  14. 14.
    Yousuf MA, Haq S, O’Donnell RE, Attari M (2015) Hemodynamically significant atrial septal defect after atrial fibrillation ablation: a hole to remember. Heart Rhythm 12:1987–1989CrossRefPubMedGoogle Scholar
  15. 15.
    Wang JK, Chiu SN, Lin MT, Chen CA, Lu CW, Wu MH (2017) Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect in patients older than 40 years. Heart Vessels 32:467–473CrossRefPubMedGoogle Scholar
  16. 16.
    Murakami T, Nakazawa G, Horinouchi H, Torii S, Ijichi T, Ohno Y, Amino M, Shinozaki N, Ogata N, Yoshimachi F, Yoshioka K, Ikari Y (2017) Transcatheter closure of atrial septal defect protects from pulmonary edema: septal occluder device gradually reduces LR shunt. Heart Vessels 32:101–104CrossRefPubMedGoogle Scholar
  17. 17.
    Rich ME, Tseng A, Lim HW, Wang PJ, Su WW (2015) Reduction of iatrogenic atrial septal defects with an anterior and inferior transseptal puncture site when operating the cryoballoon ablation catheter. J Vis Exp 100:e52811Google Scholar
  18. 18.
    Matoshvili Z, Bastani H, Bourke T, Braunschweig F, Drca N, Gudmundsson K, Insulander P, Jemtrén A, Kennebäck G, Saluveer O, Schwieler J, Tapanainen J, Wredlert C, Jensen-Urstad M (2017) Safety of fluoroscopy-guided transseptal approach for ablation of left-sided arrhythmias. Europace 19:2023–2026CrossRefPubMedGoogle Scholar
  19. 19.
    Winkle RA, Mead RH, Engel G, Patrawala RA (2011) The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation. Heart Rhythm 8:1411–1415CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  • Tomonori Watanabe
    • 1
  • Shinsuke Miyazaki
    • 1
  • Takatsugu Kajiyama
    • 1
  • Sadamitsu Ichijo
    • 1
  • Takamitsu Takagi
    • 1
  • Miyako Igarashi
    • 1
  • Hiroaki Nakamura
    • 1
  • Hiroshi Taniguchi
    • 1
  • Hitoshi Hachiya
    • 1
  • Yoshito Iesaka
    • 1
  1. 1.Cardiology Division, Cardiovascular CenterTsuchiura Kyodo HospitalTsuchiuraJapan

Personalised recommendations